biotech investing

“Taking on a challenge is a lot like riding a horse; if you're comfortable while you're doing it, you're probably doing it wrong” Ted Lasso

Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into 2026.

Mr Frazis plans to bring his brash style to more ASX investors with the launch of a tech stock focused ETF by October.

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market.

The recent “Most Favoured Nation” executive order is creating an overhang on biotech stocks and opportunities for selective stock-pickers.

Specialist expertise, months of due dilligence, and high conviction investments - KP Rx's formula for healthcare growth investing.

This business is up more than 20-fold in 5 years, with brokers and fund managers lining up to call it a buy.

The Aussie biotech space is small but mighty – what will it take to see it surge?

Dr Bianca Ogden and Hashan De Silva share the companies and trials they find interesting in the constantly innovating biotech sector.

LTR Pharma is a clinical-stage pharmaceutical company, commercialising a world first in erectile dysfunction, Spontan, a PDE5 nasal spray.